Phase I Study of Oral Darinaparsin (ZIO-101-C) in Advanced Solid Tumors and Non-Hodgkin's Lymphomas.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2013
At a glance
- Drugs Darinaparsin (Primary)
- Indications Non-Hodgkin's lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 18 Jul 2012 Planned end date changed from 1 Sep 2010 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 23 Sep 2009 Official Title amended as reported by ClinicalTrials.gov.
- 23 Sep 2009 Planned end date changed from Aug 2009 to Sep 2010 as reported by ClinicalTrials.gov.